Terms: = Lung cancer AND HIP1, ILWEQ, 3092, ENSG00000127946 AND Prognosis
3 results:
1. Therapeutic Advances of Rare ALK Fusions in Non-Small Cell lung cancer.
Xiang Y; Zhang S; Fang X; Jiang Y; Fang T; Liu J; Lu K
Curr Oncol; 2022 Oct; 29(10):7816-7831. PubMed ID: 36290895
[TBL] [Abstract] [Full Text] [Related]
2. Effectiveness of Postoperative or Preoperative Radiotherapy on prognosis in Patients with Stage II Resectable Non-Small Cell lung cancer: A Retrospective Study Based on the SEER Database.
Chen D; Yu J
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833420
[No Abstract] [Full Text] [Related]
3. Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial-Mesenchymal Transition.
Hsu CY; Lin CH; Jan YH; Su CY; Yao YC; Cheng HC; Hsu TI; Wang PS; Su WP; Yang CJ; Huang MS; Calkins MJ; Hsiao M; Lu PJ
Am J Respir Crit Care Med; 2016 Apr; 193(8):869-80. PubMed ID: 26595459
[TBL] [Abstract] [Full Text] [Related]
